{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:46:32Z","timestamp":1781282792445,"version":"3.54.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Protective host responses in those exposed to or infected with tuberculosis (TB) is thought to require a delicate balance between pro-inflammatory and regulatory immune responses. Myeloid-derived suppressor cells (MDSCs), regulatory cells that dampen T-cell function, have been described in cancer and other infectious diseases but there are limited data on their role in TB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Peripheral blood was obtained from patients with active pulmonary TB and participants with presumed latent TB infection (LTBI) from Cape Town, South Africa. MDSC frequency was ascertained by flow cytometry. Purified MDSCs were used to assess (i) their suppressive effect on T-cell proliferation using a Ki67 flow cytometric assay and (ii) their effect on mycobacterial containment by co-culturing with H37<jats:italic>Rv<\/jats:italic>-infected monocyte-derived macrophages and autologous pre-primed effector T-cells with or without MDSCs. Mycobacterial containment was measured by plating colony forming units (CFU).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MDSCs (CD15<jats:sup>+<\/jats:sup>HLA-DR<jats:sup>-<\/jats:sup>CD33<jats:sup>+<\/jats:sup>) had significantly higher median frequencies (IQR) in patients with active TB (n=10) versus LTBI (n= 10) [8.2% (6.8-10.7) versus 42.2% (27\u201356) respectively; p=0.001]. Compared to MDSC-depleted peripheral blood mononuclear and effector T cell populations, dilutions of purified MDSCs isolated from active TB patients suppressed T-cell proliferation by up to 72% (n=6; p=0.03) and significantly subverted effector T-cell-mediated containment of H37<jats:italic>Rv<\/jats:italic> in monocyte-derived macrophages (n=7; 0.6% versus 8.5%; p=0.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Collectively, these data suggest that circulating MDSCs are induced during active TB disease and can functionally suppress T-cell proliferation and subvert mycobacterial containment. These data may inform the design of vaccines and immunotherapeutic interventions against TB but further studies are required to understand the mechanisms underpinning the effects of MDSCs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.676679","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T12:36:12Z","timestamp":1622637372000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report"],"prefix":"10.3389","volume":"12","author":[{"given":"Malika","family":"Davids","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Pooran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liezel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tomasicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"B1","unstructured":"WHO Global Tuberculosis Report2020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2016.02.010","article-title":"Drug-Resistant Tuberculosis: Challenges and Progress","volume":"30","author":"Kurz","year":"2016","journal-title":"Infect Dis Clinics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-Analysis of the Published Literature","volume":"271","author":"Colditz","year":"1994","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG Vaccination Against Mycobacterium Tuberculosis Infection in Children: Systematic Review and Meta-Analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and Efficacy of MVA85A, a New Tuberculosis Vaccine, in Infants Previously Vaccinated With BCG: A Randomised, Placebo-Controlled Phase 2b Trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909953","article-title":"Final Analysis of a Trial of M72\/AS01E Vaccine to Prevent Tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"New Engl J Med"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2014.09.003","article-title":"Orchestration of Pulmonary T Cell Immunity During Mycobacterium Tuberculosis Infection: Immunity Interruptus","volume-title":"Semin Immunol","author":"Behar","year":"2014"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/9781683670131.ch64","article-title":"Immunology of Mycobacterium Tuberculosis Infections","author":"Sia","year":"2019","journal-title":"Gram-Positive Pathog"},{"key":"B9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/cells9030561","article-title":"Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer","volume":"9","author":"Law","year":"2020","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040895","article-title":"The Biology of Myeloid-Derived Suppressor Cells: The Blessing and the Curse of Morphological and Functional Heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201707-1441OC","article-title":"Regulatory T Cells Subvert Mycobacterial Containment in Patients Failing Extensively Drug-Resistant Tuberculosis Treatment","volume":"198","author":"Davids","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201210-1934OC","article-title":"Regulatory T Cells Attenuate Mycobacterial Stasis in Alveolar and Blood-Derived Macrophages From Patients With Tuberculosis","volume":"187","author":"Semple","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased Frequency of Myeloid-Derived Suppressor Cells During Active Tuberculosis and After Recent Mycobacterium Tuberculosis Infection Suppresses T-cell Function","volume":"188","author":"Du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0123772","DOI":"10.1371\/journal.pone.0123772","article-title":"Granulocytic Myeloid Derived Suppressor Cells Expansion During Active Pulmonary Tuberculosis is Associated With High Nitric Oxide Plasma Level","volume":"10","author":"El Daker","year":"2015","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S3-O18","article-title":"Role of Myeloid Derived Suppressor Cells in Tuberculosis Infection and Disease","volume":"14","author":"Kumar","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.imlet.2013.12.003","article-title":"Identification of CD244-expressing Myeloid-Derived Suppressor Cells in Patients With Active Tuberculosis","volume":"158","author":"Yang","year":"2014","journal-title":"Immunol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646658","article-title":"Phenotypically Resembling Myeloid Derived Suppressor Cells are Increased in Children With HIV and Exposed\/Infected With Mycobacterium Tuberculosis","volume":"47","author":"Du Plessis","year":"2017","journal-title":"Eur J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-9-90","article-title":"Functional Characterization of Human Cd33+ and Cd11b+ Myeloid-Derived Suppressor Cell Subsets Induced From Peripheral Blood Mononuclear Cells Co-Cultured With a Diverse Set of Human Tumor Cell Lines","volume":"9","author":"Lechner","year":"2011","journal-title":"J Trans Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02417","article-title":"Human Monocytic Suppressive Cells Promote Replication of Mycobacterium Tuberculosis and Alter Stability of In Vitro Generated Granulomas","volume":"9","author":"Agrawal","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903348","article-title":"Mycobacterium Bovis Bacillus Calmette-Gu\u00e9rin Vaccination Mobilizes Innate Myeloid-Derived Suppressor Cells Restraining In Vivo T Cell Priming Via IL-1R\u2013dependent Nitric Oxide Production","volume":"184","author":"Martino","year":"2010","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-Residing Myeloid-Derived Suppressors Display Dual Functionality in Murine Pulmonary Tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy657","article-title":"The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium Tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor","volume":"219","author":"Tomasicchio","year":"2019","journal-title":"J Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.676679\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T12:36:17Z","timestamp":1622637377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.676679\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2021.676679"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.676679","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"article-number":"676679"}}